# Deerfield's Biotech Investments: 66 Startups in Its Portfolio (2026)

> The 66 Biotech startups Deerfield has backed, by stage: $8.6B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/deerfield-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Stage not reported

22

- [Abivax](https://millionrounds.com/company/abivax)
- [Nuvalent](https://millionrounds.com/company/nuvalent)
- [Valneva](https://millionrounds.com/company/valneva)
- [TriNetX](https://millionrounds.com/company/trinetx)
- [Schrödinger](https://millionrounds.com/company/schrodinger)
- [Ascend Advanced Therapies](https://millionrounds.com/company/ascend-advanced-therapies)
- [Great Lakes Discoveries LLC](https://millionrounds.com/company/great-lakes-discoveries-llc)
- [*TP* Tris Pharam](https://millionrounds.com/company/tris-pharam)
- [Braeburn](https://millionrounds.com/company/braeburn)
- [Ribon Therapeutics](https://millionrounds.com/company/ribon-therapeutics)
- [Pinnacle Hill](https://millionrounds.com/company/pinnacle-hill)
- [Ancora Innovation](https://millionrounds.com/company/ancora-innovation)
- [*PI* Poseidon Innovation](https://millionrounds.com/company/poseidon-innovation)
- [Lakeside Discovery](https://millionrounds.com/company/lakeside-discovery)
- [Werewolf Therapeutics](https://millionrounds.com/company/werewolf-therapeutics)
- [Sollis](https://millionrounds.com/company/sollis)
- [Blade Therapeutics](https://millionrounds.com/company/blade-therapeutics)
- [*W* Wellfount](https://millionrounds.com/company/wellfount)
- [*C* ConcertoHealth](https://millionrounds.com/company/concertohealth)
- [*TW* Third Wave Technologies](https://millionrounds.com/company/third-wave-technologies)
- [*CM* Cystetic Medicines](https://millionrounds.com/company/cystetic-medicines)
- [Elutia](https://millionrounds.com/company/elutia)

## Series A

15

- [Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals)
- [Bitterroot Bio](https://millionrounds.com/company/bitterroot-bio)
- [Oncorus](https://millionrounds.com/company/oncorus)
- [Apertura Gene Therapy](https://millionrounds.com/company/apertura-gene-therapy)
- [Vicinitas Therapeutics](https://millionrounds.com/company/vicinitas-therapeutics)
- [Adela](https://millionrounds.com/company/adela)
- [Civetta Therapeutics](https://millionrounds.com/company/civetta-therapeutics)
- [Stelexis Therapeutics](https://millionrounds.com/company/stelexis-therapeutics)
- [*D* Dracen](https://millionrounds.com/company/dracen)
- [Innervace](https://millionrounds.com/company/innervace)
- [*S* Strata](https://millionrounds.com/company/strata)
- [Advanced Medicine Partners](https://millionrounds.com/company/advanced-medicine-partners)
- [*CT* Chondiral Therapeutics](https://millionrounds.com/company/chondiral-therapeutics)
- [*A* Appello](https://millionrounds.com/company/appello)
- [NeuroFlow](https://millionrounds.com/company/neuroflow)

## Series C and later

13

- [ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics)
- [*IM* Insilico Medicine](https://millionrounds.com/company/insilico-medicine)
- [LetsGetChecked](https://millionrounds.com/company/letsgetchecked)
- [Metacrine](https://millionrounds.com/company/metacrine)
- [Kolltan Pharmaceuticals](https://millionrounds.com/company/kolltan-pharmaceuticals)
- [MedAvail](https://millionrounds.com/company/medavail)
- [Strata Oncology](https://millionrounds.com/company/strata-oncology)
- [Shockwave Medical](https://millionrounds.com/company/shockwave-medical)
- [Frontier Medicines](https://millionrounds.com/company/frontier-medicines)
- [*BD* Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics)
- [NeoChord](https://millionrounds.com/company/neochord)
- [SentreHEART](https://millionrounds.com/company/sentreheart)
- [*F* Fractyl](https://millionrounds.com/company/fractyl)

## Series B

12

- [Global Blood Therapeutics](https://millionrounds.com/company/global-blood-therapeutics)
- [Editas Medicine](https://millionrounds.com/company/editas-medicine)
- [Acutus Medical](https://millionrounds.com/company/acutus-medical)
- [*N* Neomorph](https://millionrounds.com/company/neomorph)
- [Voyager Therapeutics](https://millionrounds.com/company/voyager-therapeutics)
- [Generation Bio](https://millionrounds.com/company/generation-bio)
- [Conventus Orthopaedics](https://millionrounds.com/company/conventus-orthopaedics)
- [Actio Biosciences](https://millionrounds.com/company/actio-biosciences)
- [FogPharma](https://millionrounds.com/company/fogpharma)
- [Nivalis Therapeutics](https://millionrounds.com/company/nivalis-therapeutics)
- [*CT* Chondrial Therapeutics](https://millionrounds.com/company/chondrial-therapeutics)
- [Adaptive Phage Therapeutics](https://millionrounds.com/company/adaptive-phage-therapeutics)

## Pre-seed and seed

2

- [*R* Rhythm](https://millionrounds.com/company/rhythm)
- [UTR Therapeutics Inc.](https://millionrounds.com/company/utr-therapeutics-inc)

## Growth

2

- [Epic Sciences](https://millionrounds.com/company/epic-sciences)
- [Hana Biosciences](https://millionrounds.com/company/hana-biosciences)

## Segment by segment

### Stage not reported

22 startups · $3.2B raised

- [**Abivax**](https://millionrounds.com/company/abivax) Abivax develops medicines that alter the body's natural immune system mechanisms. France $793M
- [**Nuvalent**](https://millionrounds.com/company/nuvalent) Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines. United States $500M
- [**Valneva**](https://millionrounds.com/company/valneva) Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases. France $310M
- [**TriNetX**](https://millionrounds.com/company/trinetx) TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies. United States $240M
- [**Schrödinger**](https://millionrounds.com/company/schrodinger) Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotec United States $195M
- [**Ascend Advanced Therapies**](https://millionrounds.com/company/ascend-advanced-therapies) Ascend Advanced Therapies is a Contract Development and Manufacturing Organization (CDMO) that specializes in advanced therapies, United States $131M
- [**Great Lakes Discoveries LLC**](https://millionrounds.com/company/great-lakes-discoveries-llc) Great Lakes Discoveries is a company set up by University of Michigan to boost drug commercialisation efforts. United States $130M
- [*TP* **Tris Pharam**](https://millionrounds.com/company/tris-pharam) United States $125M

### Series A

15 startups · $1.0B raised

- [**Rhythm Pharmaceuticals**](https://millionrounds.com/company/rhythm-pharmaceuticals) Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics United States $311M
- [**Bitterroot Bio**](https://millionrounds.com/company/bitterroot-bio) Bitterroot Bio, Inc. United States $145M
- [**Oncorus**](https://millionrounds.com/company/oncorus) Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer. United States $77M
- [**Apertura Gene Therapy**](https://millionrounds.com/company/apertura-gene-therapy) Apertura Gene Therapy is a biotechnology company focused on developing advanced gene therapies for rare and genetic diseases. United Kingdom $67M
- [**Vicinitas Therapeutics**](https://millionrounds.com/company/vicinitas-therapeutics) Vicinitas Therapeutics is a biotechnology company founded in 2022 and based in South San Francisco, California. United States $65M
- [**Adela**](https://millionrounds.com/company/adela) Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests. United States $65M
- [**Civetta Therapeutics**](https://millionrounds.com/company/civetta-therapeutics) Civetta Therapeutics was a biotechnology company based in Cambridge, Massachusetts, founded in 2019. United States $53M
- [**Stelexis Therapeutics**](https://millionrounds.com/company/stelexis-therapeutics) Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies. United States $43M

### Series C and later

13 startups · $2.2B raised

- [**ADC Therapeutics**](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. Switzerland $646M
- [*IM* **Insilico Medicine**](https://millionrounds.com/company/insilico-medicine) Hong Kong SAR China $392M
- [**LetsGetChecked**](https://millionrounds.com/company/letsgetchecked) LetsGetChecked is a global virtual care and health diagnostics company founded in Dublin, Ireland, in 2014. Ireland $207M
- [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M
- [**Kolltan Pharmaceuticals**](https://millionrounds.com/company/kolltan-pharmaceuticals) Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics. United States $146M
- [**MedAvail**](https://millionrounds.com/company/medavail) MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products. Canada $140M
- [**Strata Oncology**](https://millionrounds.com/company/strata-oncology) Strata Oncology is a precision oncology company dedicated to transforming cancer care. United States $90M
- [**Shockwave Medical**](https://millionrounds.com/company/shockwave-medical) Shockwave Medical is a medical device company that develops Intravascular Lithotripsy (IVL) for treating calcified coronary diseases. United States $88M

### Series B

12 startups · $1.9B raised

- [**Global Blood Therapeutics**](https://millionrounds.com/company/global-blood-therapeutics) GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease. United States $389M
- [**Editas Medicine**](https://millionrounds.com/company/editas-medicine) Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases. United States $335M
- [**Acutus Medical**](https://millionrounds.com/company/acutus-medical) Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. United States $268M
- [*N* **Neomorph**](https://millionrounds.com/company/neomorph) United States $209M
- [**Voyager Therapeutics**](https://millionrounds.com/company/voyager-therapeutics) Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology. United States $205M
- [**Generation Bio**](https://millionrounds.com/company/generation-bio) Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders. United States $176M
- [**Conventus Orthopaedics**](https://millionrounds.com/company/conventus-orthopaedics) Conventus Orthopaedics is a provider of a range of orthopedic and sports medicine services. United States $94M
- [**Actio Biosciences**](https://millionrounds.com/company/actio-biosciences) Actio Biosciences is a research center that develops drugs for rare diseases. United States $66M

### Pre-seed and seed

2 startups · $43M raised

- [*R* **Rhythm**](https://millionrounds.com/company/rhythm) United States $42M
- [**UTR Therapeutics Inc.**](https://millionrounds.com/company/utr-therapeutics-inc) UTR Therapeutics Inc. United States $400K

### Growth

2 startups · $281M raised

- [**Epic Sciences**](https://millionrounds.com/company/epic-sciences) Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine. United States $165M
- [**Hana Biosciences**](https://millionrounds.com/company/hana-biosciences) Talon Therapeutics is a biopharmaceutical company develops and commercializes new and differentiated cancer therapies. United States $116M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Deerfield as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **Deerfield's Healthtech portfolio** 17 startups · $2.5B](https://millionrounds.com/portfolio-maps/deerfield-healthtech-portfolio)[Portfolio map **Deerfield portfolio map** 99 startups · $13B](https://millionrounds.com/portfolio-maps/deerfield-portfolio-map)[Co-investors **Who invests with Deerfield** 62 co-investors](https://millionrounds.com/portfolio-maps/deerfield-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)

## Raising from investors like Deerfield?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
